Terrier P, Mouriesse H, Loridon B, Gotteland M, May-Levin F, Delarue J-C. Use of a Polyclonal Antibody for the Determination of the Prognostic Value of c-erbB-2 Protein Over-Expression in Human Breast Cancer. AO [Internet]. 1996 Jan. 1 [cited 2026 May 21];35(1):23-30. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/27551